|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 46.61 USD | +1.66% |
|
+0.84% | +11.61% |
| 05-26 | Nisource Insider Sold Shares Worth $950,066, According to a Recent SEC Filing | MT |
| 05-12 | Jefferies Adjusts Price Target on NiSource to $56 From $55, Maintains Buy Rating | MT |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 2.84 | 2.92 | 2.76 | 2.89 | 3.37 | |||||
Return on Total Capital | 3.97 | 4.07 | 3.66 | 3.7 | 4.34 | |||||
Return On Equity % | 8.98 | 10.44 | 7.48 | 8.12 | 9.07 | |||||
Return on Common Equity | 10.31 | 13.11 | 9.58 | 8.96 | 10.22 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 42.18 | 38.65 | 45.2 | 51.74 | 50.61 | |||||
SG&A Margin | -0.41 | -0.29 | 0.64 | 0.52 | 0.41 | |||||
EBITDA Margin % | 35.49 | 33.26 | 38.01 | 43.84 | 43.47 | |||||
EBITA Margin % | 21.76 | 20.62 | 23.51 | 27.06 | 28.02 | |||||
EBIT Margin % | 21.43 | 20.33 | 23.15 | 26.6 | 27.44 | |||||
Income From Continuing Operations Margin % | 12.02 | 13.53 | 12.25 | 15.48 | 15.24 | |||||
Net Income Margin % | 11.94 | 13.74 | 12.97 | 13.94 | 13.99 | |||||
Net Avail. For Common Margin % | 10.81 | 12.8 | 12.02 | 13.53 | 13.95 | |||||
Normalized Net Income Margin | 9.03 | 9.31 | 10 | 10.05 | 10.2 | |||||
Levered Free Cash Flow Margin | -12.55 | -11.71 | -29.72 | -11.88 | -16.8 | |||||
Unlevered Free Cash Flow Margin | -8.11 | -7.66 | -23.74 | -5.43 | -10.21 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.21 | 0.23 | 0.19 | 0.17 | 0.2 | |||||
Fixed Assets Turnover | 0.28 | 0.31 | 0.26 | 0.23 | 0.25 | |||||
Receivables Turnover (Average Receivables) | 5.85 | 6.15 | 5.62 | 5.79 | 6.03 | |||||
Inventory Turnover (Average Inventory) | 6.3 | 5.74 | 4.81 | 5.9 | 7.82 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 0.7 | 0.55 | 0.85 | 0.51 | 0.69 | |||||
Quick Ratio | 0.37 | 0.26 | 0.6 | 0.28 | 0.4 | |||||
Operating Cash Flow to Current Liabilities | 0.44 | 0.3 | 0.37 | 0.43 | 0.68 | |||||
Days Sales Outstanding (Average Receivables) | 62.37 | 59.39 | 64.97 | 63.26 | 60.48 | |||||
Days Outstanding Inventory (Average Inventory) | 57.97 | 63.58 | 75.92 | 62.02 | 46.66 | |||||
Average Days Payable Outstanding | 80.14 | 75.86 | 108.71 | 117.16 | 108.58 | |||||
Cash Conversion Cycle (Average Days) | 40.2 | 47.11 | 32.19 | 8.12 | -1.44 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 137.12 | 143.67 | 139.72 | 131.11 | 139.28 | |||||
Total Debt / Total Capital | 57.83 | 58.96 | 58.28 | 56.73 | 58.21 | |||||
LT Debt/Equity | 126.65 | 120.93 | 109.32 | 113.35 | 132.72 | |||||
Long-Term Debt / Total Capital | 53.41 | 49.63 | 45.61 | 49.05 | 55.47 | |||||
Total Liabilities / Total Assets | 69.89 | 70.45 | 67.38 | 66.44 | 67.48 | |||||
EBIT / Interest Expense | 3.02 | 3.14 | 2.42 | 2.58 | 2.61 | |||||
EBITDA / Interest Expense | 5.04 | 5.16 | 4 | 4.27 | 4.15 | |||||
(EBITDA - Capex) / Interest Expense | -0.24 | -0.65 | -1.03 | -0.42 | -0.36 | |||||
Total Debt / EBITDA | 5.68 | 5.8 | 6.73 | 5.81 | 5.6 | |||||
Net Debt / EBITDA | 5.64 | 5.78 | 5.66 | 5.75 | 5.56 | |||||
Total Debt / (EBITDA - Capex) | -119.72 | -45.98 | -26.13 | -59.02 | -63.86 | |||||
Net Debt / (EBITDA - Capex) | -118.71 | -45.81 | -21.99 | -58.36 | -63.43 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 4.65 | 19.41 | -5.9 | -0.91 | 21.76 | |||||
Gross Profit, 1 Yr. Growth % | 2.99 | 9.4 | 10.06 | 13.42 | 19.11 | |||||
EBITDA, 1 Yr. Growth % | 6.27 | 11.89 | 7.54 | 14.28 | 20.75 | |||||
EBITA, 1 Yr. Growth % | 7.9 | 13.15 | 7.3 | 14.05 | 26.05 | |||||
EBIT, 1 Yr. Growth % | 8.18 | 13.25 | 7.16 | 13.86 | 25.63 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -4.25K | 34.48 | -14.83 | 25.25 | 19.88 | |||||
Net Income, 1 Yr. Growth % | -3.42K | 37.48 | -11.17 | 6.45 | 22.24 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -770.22 | 33.22 | -12.81 | 9.52 | 20.37 | |||||
Normalized Net Income, 1 Yr. Growth % | 14.69 | 23.14 | 1 | -0.42 | 23.62 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 7.54 | 10.96 | 12.22 | 14.22 | 12.69 | |||||
Inventory, 1 Yr. Growth % | 24.33 | 50.77 | -33.08 | -22.67 | 15.52 | |||||
Accounts Receivable, 1 Yr. Growth % | 4.33 | 26.2 | -17.27 | 11.86 | 24.2 | |||||
Total Assets, 1 Yr. Growth % | 9.6 | 10.68 | 16.23 | 2.29 | 12.81 | |||||
Tangible Book Value, 1 Yr. Growth % | 15.61 | 16.04 | 38.62 | 14.3 | 10.64 | |||||
Cash From Operations, 1 Yr. Growth % | 10.32 | 15.72 | 37.3 | -7.94 | 32.6 | |||||
Capital Expenditures, 1 Yr. Growth % | 4.54 | 19.86 | 20.09 | -0.11 | 19.41 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -18.11 | 11.43 | 138.87 | -60.38 | 72.07 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -22.79 | 12.83 | 191.67 | -77.33 | 128.9 | |||||
Dividend Per Share, 1 Yr. Growth % | 5.29 | 6.7 | 6.28 | 5.91 | 6.05 | |||||
Common Equity, 1 Yr. Growth % | 10.85 | 11.63 | 29.1 | 11.57 | 8.82 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | -3.01 | 11.79 | 6 | -3.44 | 9.84 | |||||
Gross Profit, 2 Yr. CAGR % | -5.6 | 6.69 | 10.14 | 11.98 | 16.5 | |||||
EBITDA, 2 Yr. CAGR % | -5.54 | 9.04 | 9.69 | 10.86 | 17.47 | |||||
EBITA, 2 Yr. CAGR % | -9.43 | 11.48 | 11.02 | 11.42 | 20.84 | |||||
EBIT, 2 Yr. CAGR % | -9.73 | 10.68 | 10.16 | 10.46 | 19.6 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 23.97 | 646.73 | 7.02 | 3.29 | 22.54 | |||||
Net Income, 2 Yr. CAGR % | 23.56 | 575.93 | 10.51 | -2.76 | 14.07 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 20.98 | 198.81 | 7.77 | -2.38 | 14.82 | |||||
Normalized Net Income, 2 Yr. CAGR % | -12.32 | 18.84 | 11.52 | 0.29 | 10.95 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 2.73 | 9.23 | 11.59 | 13.22 | 13.45 | |||||
Inventory, 2 Yr. CAGR % | 8.36 | 36.92 | 0.45 | -28.06 | -5.49 | |||||
Accounts Receivable, 2 Yr. CAGR % | -1.84 | 14.75 | 2.18 | -3.8 | 17.86 | |||||
Total Assets, 2 Yr. CAGR % | 3.25 | 10.14 | 13.42 | 9.04 | 7.42 | |||||
Common Equity, 2 Yr. CAGR % | 2.84 | 11.24 | 20.05 | 20.02 | 10.19 | |||||
Tangible Book Value, 2 Yr. CAGR % | 3.98 | 15.83 | 26.83 | 25.88 | 12.46 | |||||
Cash From Operations, 2 Yr. CAGR % | -12.3 | 12.99 | 26.05 | 12.43 | 10.49 | |||||
Capital Expenditures, 2 Yr. CAGR % | 0.98 | 11.94 | 19.98 | 9.53 | 9.22 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 34.34 | -4.46 | 63.15 | -2.71 | -17.43 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 100.44 | -6.64 | 81.41 | -18.68 | -27.96 | |||||
Dividend Per Share, 2 Yr. CAGR % | 5.12 | 6 | 6.49 | 6.1 | 5.98 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | -1.42 | 3.95 | 5.55 | 3.64 | 4.32 | |||||
Gross Profit, 3 Yr. CAGR % | 27.37 | -0.84 | 7.8 | 11.22 | 14.31 | |||||
EBITDA, 3 Yr. CAGR % | 36.14 | -0.05 | 8.54 | 11.2 | 14.06 | |||||
EBITA, 3 Yr. CAGR % | 90.22 | -2.46 | 10.07 | 12.02 | 16.1 | |||||
EBIT, 3 Yr. CAGR % | 93.96 | -2.64 | 9.5 | 11.38 | 15.3 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 126.61 | 27.38 | 262.14 | 12.78 | 8.54 | |||||
Net Income, 3 Yr. CAGR % | 126.11 | 28.04 | 243.66 | 9.14 | 4.95 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 90.56 | 24.93 | 98.19 | 8.35 | 4.68 | |||||
Normalized Net Income, 3 Yr. CAGR % | 56.73 | -1.81 | 12.57 | 7.39 | 7.53 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 4.85 | 5.4 | 10.22 | 12.46 | 13.04 | |||||
Inventory, 3 Yr. CAGR % | 5.68 | 20.97 | 7.85 | -7.94 | -15.76 | |||||
Accounts Receivable, 3 Yr. CAGR % | -7.95 | 6.73 | 2.89 | 5.31 | 4.75 | |||||
Total Assets, 3 Yr. CAGR % | 3.47 | 5.67 | 12.13 | 9.58 | 10.28 | |||||
Common Equity, 3 Yr. CAGR % | 3.5 | 5.69 | 16.9 | 17.15 | 16.16 | |||||
Tangible Book Value, 3 Yr. CAGR % | 9.77 | 7.86 | 22.97 | 22.51 | 20.58 | |||||
Cash From Operations, 3 Yr. CAGR % | 31.13 | -3.8 | 20.57 | 13.52 | 18.79 | |||||
Capital Expenditures, 3 Yr. CAGR % | 0.36 | 6.92 | 14.6 | 12.87 | 12.73 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | -19.5 | 26.22 | 29.67 | 1.79 | 17.66 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | -25.89 | 65.5 | 36.48 | -9.3 | 14.81 | |||||
Dividend Per Share, 3 Yr. CAGR % | 4.47 | 5.64 | 6.09 | 6.3 | 6.08 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 1.75 | 3.72 | 1.48 | 0.93 | 7.25 | |||||
Gross Profit, 5 Yr. CAGR % | 3.88 | 4.62 | 19.99 | 4 | 11.1 | |||||
EBITDA, 5 Yr. CAGR % | 5 | 6.17 | 24.87 | 4.18 | 12.03 | |||||
EBITA, 5 Yr. CAGR % | 4.19 | 5.41 | 52.9 | 2.58 | 13.9 | |||||
EBIT, 5 Yr. CAGR % | 4.14 | 5.36 | 54.69 | 2.4 | 13.43 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 12.18 | 43.86 | 67.86 | 17.13 | 134.76 | |||||
Net Income, 5 Yr. CAGR % | 12.03 | 44.3 | 69.8 | 14.7 | 121.08 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 4.54 | 34.18 | 51.72 | 13.24 | 59.31 | |||||
Normalized Net Income, 5 Yr. CAGR % | 6.67 | 9.26 | 36.79 | -0.98 | 11.92 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 6.51 | 6.72 | 7.49 | 8.46 | 11.5 | |||||
Inventory, 5 Yr. CAGR % | 0.17 | 9.8 | 3.56 | -1.74 | 2.3 | |||||
Accounts Receivable, 5 Yr. CAGR % | -0.51 | 3 | -4.02 | 2.39 | 8.64 | |||||
Total Assets, 5 Yr. CAGR % | 5.26 | 6.02 | 7.34 | 7 | 10.22 | |||||
Common Equity, 5 Yr. CAGR % | 5.82 | 6.89 | 9.83 | 11.2 | 14.17 | |||||
Tangible Book Value, 5 Yr. CAGR % | 12.86 | 13.63 | 16.3 | 14.73 | 18.65 | |||||
Cash From Operations, 5 Yr. CAGR % | 8.68 | 13.68 | 29.08 | 2.39 | 16.43 | |||||
Capital Expenditures, 5 Yr. CAGR % | 4.5 | 5.37 | 7.79 | 7.96 | 12.41 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | -5.78 | -0.53 | 6.79 | 13.74 | 8.25 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | -8.07 | -1.17 | 6.02 | 24.55 | 5.69 | |||||
Dividend Per Share, 5 Yr. CAGR % | 6.28 | 5.81 | 5.27 | 5.82 | 6.05 |
- Stock Market
- Equities
- NI Stock
- Financials NiSource, Inc.
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















